Helmholtz Gemeinschaft


Sex differences in autoimmune disorders of the central nervous system

Item Type:Review
Title:Sex differences in autoimmune disorders of the central nervous system
Creators Name:Gold, S.M., Willing, A., Leypoldt, F., Paul, F. and Friese, M.A.
Abstract:Stronger adaptive immune responses in females can be observed in different mammals, resulting in better control of infections compared to males. However, this presumably evolutionary difference likely also drives higher incidence of autoimmune diseases observed in humans. Here, we summarize sex differences in the most common autoimmune diseases of the central nervous system (CNS) and discuss recent advances in the understanding of possible underlying immunological and CNS intrinsic mechanisms. In multiple sclerosis (MS), the most common inflammatory disease of the CNS, but also in rarer conditions, such as neuromyelitis optica spectrum disorders (NMOSD) or neuronal autoantibody-mediated autoimmune encephalitis (AE), sex is one of the top risk factors, with women being more often affected than men. Immunological mechanisms driving the sex bias in autoimmune CNS diseases are complex and include hormonal as well as genetic and epigenetic effects, which could also be exerted indirectly via modulation of the microbiome. Furthermore, CNS intrinsic differences could underlie the sex bias in autoimmunity by differential responses to injury. The strong effects of sex on incidence and possibly also activity and progression of autoimmune CNS disorders suggest that treatments need to be tailored to each sex to optimize efficacy. To date, however, due to a lack of systematic studies on treatment responses in males versus females, evidence in this area is still sparse. We argue that studies taking sex differences into account could pave the way for sex-specific and therefore personalized treatment.
Keywords:Autoantibodies, Central Nervous System, Encephalitis, Hashimoto Disease, Incidence, Multiple Sclerosis, Neuromyelitis Optica, Sex Characteristics, Animals
Source:Seminars in Immunopathology
Page Range:177-188
Date:March 2019
Official Publication:https://doi.org/10.1007/s00281-018-0723-8
PubMed:View item in PubMed

Repository Staff Only: item control page

Open Access
MDC Library